, Système cardiaque, anatomo-physiologie cardiaque
Cardiologie: le fonctionnement électrique du coeur ,
, Collège National de Pharmacologie Médical
Physiologie des systèmes intégrés, les principes et fonctions-L'électrocardiogramme (ECG) ,
Arythmie cardiaque, guide d'apprentissage". Presses universitaires de l, vol.148, 2005. ,
Molecular and cellular mechanisms of cardiac arrhythmias, Cell, vol.104, issue.4, pp.569-80, 2001. ,
Sudden cardiac death". Circulation, vol.98, pp.2334-51, 1998. ,
, Antiarythmiques". EMC-Cardiologie, 2013.
Fabuleux hasards: histoire de la découverte de médicaments, vol.139, 2012. ,
Plants in cardiology, Br Heart J, vol.67, p.116, 1992. ,
Drug Discovery: A History ,
Amiodarone et thyroïde", Rev Med Suisse, vol.8, pp.2175-2180, 2012. ,
Amiodarone: Electrophysiologic actions, pharmacokinetics and clinical effects, J Am Coll Cardiol, vol.3, issue.4, pp.1059-71, 1984. ,
Absolute bioavailability of amiodarone in normal subjects, Clin Pharmacol Ther, vol.37, issue.2, pp.118-141, 1985. ,
Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia". Vasc Health Risk Manag, vol.6, pp.465-472, 2010. ,
Dramatic inhibition of amiodarone metabolism induced by grapefruit juice, Br J Clin Pharmacol, vol.49, issue.4, pp.373-381, 2000. ,
Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: Prediction of in vivo drug interactions, Br J Clin Pharmacol, vol.49, issue.3, pp.244-53, 2000. ,
Effects of Amiodarone and N-desethylamiodarone on Cardiac Voltage-Gated Sodium Channels, Front Pharmacol, vol.7, issue.3, pp.244-53, 2016. ,
Suivi thérapeutique pharmacologique de l'amiodarone, EMC-Biologie médicale, pp.1-3, 2006. ,
Commission de la transparence sur la cordarone®, 2012. ,
Rapport d'activite 2002-rapport-institutionnel-9339, 2002. ,
,
, Drug Safety Information for Heathcare Professionals-Information for Healthcare Professionals: Amiodarone, 2013.
Amiodarone pulmonary toxicity: cytopathology, ultrastructure, and immunocytochemistry, Ann Diagn Pathol, vol.1, issue.1, pp.47-56, 1997. ,
Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation, Am J Cardiol, vol.52, issue.8, pp.975-984, 1983. ,
The incidence and predictors of overall adverse effects caused by low dose amiodarone in real-world clinical practice, Korean J Intern Med, vol.29, issue.5, pp.588-596, 2014. ,
Ocular Side Effects of Amiodarone, Surv Ophthalmol, vol.42, issue.4, pp.360-366, 1998. ,
Ocular Effects in long-term amiodarone therapy, Am Heart J, vol.106, issue.4, pp.902-907, 1983. ,
Ocular changes resulting from therapy with amiodarone, Br J Ophthalmol, vol.66, issue.10, pp.676-685, 1982. ,
Le nerf optique : anatomie, fonction et maladies fréquentes ,
Diagnostic d'une neuropathie optique toxique et/ou carentielle, Jr Fr Opht, issue.7, pp.765-770, 2003. ,
Albert & Jakobiec's Principles & Practice of Ophthalmology, vol.5502, p.27, 2008. ,
Atteintes ophtalmologiques des traitements systémiques, EMC-Ophtalmologie, vol.12, issue.3, pp.1-12, 2015. ,
Neuropathie optiques liées à l'amiodarone-à propos de deux cas" 26 janvier, 2007. ,
Amiodarone keratopathy: drug-induced lipid storage disease, Arch Ophthalmol, vol.99, issue.2, pp.257-61, 1981. ,
Amiodarone-associated optic neuropathy: A critical review, Am J Med, vol.125, issue.5, pp.447-53, 2012. ,
Cutaneous adverse reactions of amiodarone". ed Sci Monit, vol.20, pp.2369-72, 2014. ,
Prescribing amiodarone: an evidence-based review of clinical indications, JAMA, vol.298, issue.11, pp.1312-1334, 2007. ,
Adverse Effects of Low Dose Amiodarone: A Meta-Analysis, J Am Coll Cardiol, vol.30, issue.3, pp.791-799, 1997. ,
Amiodarone-a "Broad Spectrum" antiarrhythmic drug, Cardiovasc Hematol Disord Drug Targets, vol.10, issue.1, pp.73-81, 2010. ,
Photodistribution of blue-gray hyperpigmentation after amiodarone treatment: molecular characterization of amiodarone in the skin, Arch Dermatol, vol.144, issue.1, p.92, 2008. ,
, Institut national de la santé et de la recherche médicale
Amiodarone et thyroïde", Rev Med Suisse, vol.8, pp.2175-2180, 2012. ,
Management of Amiodarone-Related Thyroid Problems, Ther Adv Endocrinol Metab, vol.2, issue.3, pp.115-126, 2011. ,
The Effects of Amiodarone on the Thyroid, Endocr Rev, 2001. ,
Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy, Heart, vol.79, issue.2, pp.121-128, 1998. ,
Successful treatment of amiodarone-induced thyrotoxicosis, vol.105, pp.1275-1282, 2002. ,
Hyponatremia-a rare but serious complication of amiodarone: a case report and review of the literature, Case Rep Nephrol Urol, vol.3, pp.46-50, 2013. ,
Docetaxel-Amiodarone: association à risque ?". Faculté de médecine, université de Lorraine, vol.146, 2003. ,
Acute amiodarone pulmonary toxicity after drug holiday: A case report and review of the literature, Case Rep Cardiol, p.182154, 2015. ,
Possible association of pneumonitis with amiodarone therapy, Am Heart J, vol.100, issue.3, pp.412-415, 1980. ,
Very early onset of amiodarone-induced pulmonary toxicity, Korean Circ J, vol.43, issue.10, pp.699-701, 2013. ,
Toxicité pulmonaire de l'amiodarone, Rev Mal Resp, vol.22, pp.124-126, 2005. ,
Frequency, characteristics, and risk factors for amiodarone neurotoxicity, Arch Neurol, vol.66, issue.7, pp.865-874, 2009. ,
Frequent Neurologic Toxicity Associated with Amiodarone Therapy, Neurology, vol.34, issue.5, pp.669-71, 1984. ,
Unusual neurotoxicity associated with amiodarone therapy, Arch Intern Med, vol.147, issue.5, pp.881-885, 1987. ,
Frequency, Characteristics, and Risk Factors for Amiodarone Neurotoxicity, Arch Neurol, vol.66, issue.7, pp.865-874, 2009. ,
Amiodarone-induced liver injury and cirrhosis, ACG Case Rep J, 2015. ,
Amiodarone-induced hepatic phospholipidosis: a morphological alteration independent of pseudoalcoholic liver disease, Hepatology, vol.8, issue.5, pp.1063-1071, 1988. ,
, Base de données Livertox
Adverse effects of low dose amiodarone: a meta-analysis, J Am Coll Cardiol, vol.30, issue.3, pp.791-799, 1997. ,
Hépatotoxicité à la suite de l'utilisation à court terme d'amiodarone pour une personne âgée: un report de cas, Can J Hosp Pharm, vol.66, issue.3, pp.190-193, 2013. ,
Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis, Am J Health Syst Pharm, vol.63, issue.9, pp.829-866, 2006. ,
Extreme bradycardia after first doses of sofosbuvir and daclatasvir in patients receiving amiodarone: 2 Cases including a rechallenge, Gastroenterology, vol.149, issue.6, pp.1378-1380, 2015. ,
Epidemiology of symptomatic drug-Induced long QT syndrome and torsade de pointes in Germany, Europace, vol.16, issue.1, pp.101-109, 2014. ,
Amiodarone associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia, Ann Intern Med, vol.121, issue.7, pp.529-564, 1994. ,
, Résumé des Caractéristiques du Produit. Cordarone 200 mg, comprimé sécable